IT1132168B - Agente immunoterapeutico per tumori comprendente lipopolisaccaride come un componente attivo - Google Patents

Agente immunoterapeutico per tumori comprendente lipopolisaccaride come un componente attivo

Info

Publication number
IT1132168B
IT1132168B IT23219/80A IT2321980A IT1132168B IT 1132168 B IT1132168 B IT 1132168B IT 23219/80 A IT23219/80 A IT 23219/80A IT 2321980 A IT2321980 A IT 2321980A IT 1132168 B IT1132168 B IT 1132168B
Authority
IT
Italy
Prior art keywords
active component
immunotherapeutic agent
cancer including
including lipopolysaccharide
lipopolysaccharide
Prior art date
Application number
IT23219/80A
Other languages
English (en)
Italian (it)
Other versions
IT8023219A0 (it
Inventor
Chisato Maruyama
Original Assignee
Chisato Maruyama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chisato Maruyama filed Critical Chisato Maruyama
Publication of IT8023219A0 publication Critical patent/IT8023219A0/it
Application granted granted Critical
Publication of IT1132168B publication Critical patent/IT1132168B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT23219/80A 1979-07-04 1980-07-03 Agente immunoterapeutico per tumori comprendente lipopolisaccaride come un componente attivo IT1132168B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8468179A JPS568320A (en) 1979-07-04 1979-07-04 Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent

Publications (2)

Publication Number Publication Date
IT8023219A0 IT8023219A0 (it) 1980-07-03
IT1132168B true IT1132168B (it) 1986-06-25

Family

ID=13837428

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23219/80A IT1132168B (it) 1979-07-04 1980-07-03 Agente immunoterapeutico per tumori comprendente lipopolisaccaride come un componente attivo

Country Status (8)

Country Link
US (2) US4329452A (enExample)
JP (1) JPS568320A (enExample)
CA (1) CA1132047A (enExample)
CH (1) CH650799A5 (enExample)
ES (1) ES493061A0 (enExample)
FR (1) FR2484258A1 (enExample)
IT (1) IT1132168B (enExample)
SU (1) SU1232124A3 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5718619A (en) * 1980-07-10 1982-01-30 Chisato Maruyama Tumor immunotherapy agent containing lipopolysaccharide as active principle
JPS59161320A (ja) * 1983-03-04 1984-09-12 Maruyama Chisato リポ多糖体およびその製造法
US4612304A (en) * 1985-06-11 1986-09-16 Ss Pharmaceutical Co., Ltd. Antitumor formulation containing lipopolysaccharide with trehalose derivatives
US4818751A (en) * 1985-07-02 1989-04-04 Zeria Shinyaku Kogyo Kabushiki Kaisha Cosmetics
DK316188A (da) * 1987-06-15 1988-12-16 Duphar Int Res Sulfolipopolysaccharider som stimolatorer for den ikke specifikke forsvarsmekanisme
US4798369A (en) * 1987-11-03 1989-01-17 The Firestone Tire & Rubber Company Ultrasonic air spring system
US5853737A (en) * 1992-12-10 1998-12-29 Brigham And Women's Hospital Method for inducing a CD1-restricted immune response
US6238676B1 (en) * 1992-12-10 2001-05-29 Brigham And Women's Hospital Presentation of hydrophobic antigens to T-cells by CD1 molecules
US7063844B2 (en) 1992-12-10 2006-06-20 The Brigham And Women's Hospital, Inc. Presentation of hydrophobic antigens to T-cells by CD1 molecules
EP0710484A3 (en) * 1994-10-07 1996-10-23 Univ Illinois Mixture of alpha-D-glucopyranosyl- (1-6) -alpha-D glucopyranose as an anti-tumor agent
DE69724156T2 (de) * 1997-06-10 2004-05-27 Chung, Tai Ho Aus mycobacterium tuberculosis extrahierter kohlenwasserstoffkomplex und verfahren zu dessen herstellung
US5869645A (en) * 1997-10-15 1999-02-09 Board Of Trustees Of The University Of Illinois Method for isolating high molecular weight antineoplastic glycans using urea
NZ505538A (en) * 2000-07-03 2004-12-24 Malaghan Inst Of Medical Res A vaccine comprising immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide (PIM); and the use of PIM for inducing an immune response in a patient effective in the prevention or treatment of Th2-mediated diseases or disorders such as asthma
CN101022826A (zh) 2004-06-07 2007-08-22 哈罗尔·戴维·贡 用于癌症治疗的细菌组合物
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US8034359B2 (en) 2004-06-07 2011-10-11 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to cancers
US8501198B2 (en) 2004-06-07 2013-08-06 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US20070161546A1 (en) * 2005-12-15 2007-07-12 Colm King Methods and compositions for treatment of cancer
US8980279B2 (en) 2010-07-26 2015-03-17 Qu Biologics Personalized site-specific immunomodulation
JP2015157763A (ja) * 2012-05-28 2015-09-03 エヌエーアイ株式会社 認知症の治療剤及び予防剤
CA2944616A1 (en) 2014-03-31 2015-10-08 University Of Utah Research Foundation Fluid analysis device and associated systems and methods
CN106456740B (zh) 2014-05-02 2021-06-08 Qu生物制药公司 抗微生物免疫调节
AU2021357131A1 (en) * 2020-10-09 2023-05-25 Zeria Pharmaceutical Co., Ltd. Novel use of mycobacterium tuberculosis extract

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
NL7308450A (enExample) * 1972-06-20 1973-12-27
FR2227862A1 (en) * 1973-05-04 1974-11-29 Anvar Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues
DE2527636A1 (de) * 1974-06-20 1976-01-08 Anvar Verfahren zur herstellung von mycobakteriellen fraktionen

Also Published As

Publication number Publication date
JPS568320A (en) 1981-01-28
US4329452A (en) 1982-05-11
FR2484258B1 (enExample) 1984-11-30
JPS6256843B2 (enExample) 1987-11-27
FR2484258A1 (fr) 1981-12-18
IT8023219A0 (it) 1980-07-03
ES8105783A1 (es) 1981-06-16
SU1232124A3 (ru) 1986-05-15
US4394502A (en) 1983-07-19
CA1132047A (en) 1982-09-21
CH650799A5 (de) 1985-08-15
ES493061A0 (es) 1981-06-16

Similar Documents

Publication Publication Date Title
IT8023219A0 (it) Agente immunoterapeutico per tumori comprendente lipopolisaccaride come un componente attivo.
IT8067262A0 (it) Agente anti ipercolesterolemico eprocedimento per la sua preparazione
IT8048066A0 (it) Agente carcinostatico ed immunosti molante contenente lisofosfolipide e fosfolipide e procedimento per prepararlo
TR19661A (tr) Guemues katalizatoerlerin performasinin islahina mahsus usul
BR8001129A (pt) Agente antitumor
IT1091139B (it) Agente conservante per foraggio
NO834501L (no) Fremgangsmaate for opploesning av cellulosekarbamat
BE844989A (fr) Composition veterinaire
BR8000934A (pt) Agente dessulfurnate para injecao
IT8048403A0 (it) Complesso multiconduttore schermato
DE3069512D1 (de) Z-bar guide apparatus
MX148583A (es) Procedimiento mejorado para la preparacion de un compuesto de organoestano
IT1094915B (it) Perborato di sodio solido superossidato,e procedimento per fabbricarlo
FR2471028B1 (fr) Blindage anti-neutrons
SE7802751L (sv) Forfarande for framstellning av alfa-aryl-alfa,alfa-bis(omega-(disubstituerad amino)alkyl)-acetamider och beslektade foreningar
IT8021117A0 (it) Agente assorbente di ultravioletti.
IT1130783B (it) Procedimento per la preparazione di un agente per la gelificazione di fluoroelastomeri
NL7604831A (nl) Applicator voor inwendige bestraling.
NO146862C (no) Jodbenzenderivater for anvendelse som roentgenkontrastmidler
IT1129952B (it) Apparecchiatura di sviluppo per diazotipia
MX149264A (es) Procedimiento mejorado para la preparacion de un compuesto de organoestano
DK74280A (da) Immuniseringsmiddel
IT1118225B (it) Procedimento per l'ottenimento di steroidi poliossidrilati,lisergolo ed alcaloidi ergolici
FI803732L (fi) 2-amino-etanol-derivat foerfarande foer deras framstaellning saodana foereningar innehaollande farmaceutiska preparat och dessas anvaendning
BE852562A (fr) Composition veterinaire

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970730